Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$5.65 - $7.03 $1,130 - $1,406
-200 Reduced 6.06%
3,100 $18,000
Q1 2024

May 15, 2024

BUY
$5.27 - $8.03 $3,688 - $5,621
700 Added 26.92%
3,300 $19,000
Q4 2023

Feb 14, 2024

BUY
$6.17 - $8.04 $11,723 - $15,275
1,900 Added 271.43%
2,600 $20,000
Q3 2023

Nov 14, 2023

SELL
$7.02 - $10.32 $7,020 - $10,320
-1,000 Reduced 58.82%
700 $5,000
Q2 2023

Aug 14, 2023

SELL
$8.29 - $11.16 $35,646 - $47,988
-4,300 Reduced 71.67%
1,700 $17,000
Q1 2023

May 15, 2023

BUY
$9.1 - $15.48 $50,050 - $85,140
5,500 Added 1100.0%
6,000 $62,000
Q4 2022

Feb 14, 2023

BUY
$12.06 - $21.55 $6,030 - $10,775
500 New
500 $6,000

Others Institutions Holding ANGO

About ANGIODYNAMICS INC


  • Ticker ANGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 39,107,800
  • Market Cap $299M
  • Description
  • AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation syst...
More about ANGO
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.